free porn
mobile porn
free porn
porn
porno izle

Agenda

Agenda

View the Agenda

ARM’s Cell & Gene Therapy Investor Day is a full-day conference combining discussions between key opinion leaders, top analysts and senior executives in addition to presentations by the field’s most promising companies.

 

 

PROGRAM AGENDA

7:30 am REGISTRATION, BREAKFAST & NETWORKING
8:00 am WELCOME REMARKS
Speaker:
Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine
8:10 am FEATURED FIRESIDE CHAT
Moderator:
Gbola Amusa, M.D., Partner, Director of Research and Head of Healthcare Research, Chardan
Speaker:
Katherine High, M.D., President and Head of Research and Development, Spark Therapeutics
8:55 am COMPANY PRESENTATIONS
West Lounge Room Main Bar Room
8:55 am BioCardia Neuralstem
9:10 am Histogenics Frequency Therapeutics
9:25 am Vericel Celixir
9:40 am Adverum Biotechnologies Miromatrix
9:55 am NexImmune Tmunity Therapeutics
10:10 am MORNING BREAK
10:25 am PANEL I: TECHNOLOGY TRENDS: LEADING PLATFORMS ACROSS THE CELL AND GENE SECTOR
Moderator:
Amy DuRoss, CEO, Vineti
Speakers:
Donna Armentano, Ph.D., Executive Director, External Research and Development Innovation, Gene Therapy, Pfizer
James Burns, Ph.D., President and CEO, Casebia Therapeutics
Robert Deans, Ph.D., Chief Technology Officer, BlueRock Therapeutics
James Noble, CEO, Adaptimmune
11:10 am COMPANY PRESENTATIONS
West Lounge Room Main Bar Room
11:10 am Oxford BioMedica B-MoGen Biotechnologies
11:25 am bluebird bio LogicBio
11:40 am Adaptimmune Orchard Therapeutics
11:55 am Kiadis Pharma Avery Therapeutics
12:10 pm Iovance Biotherapeutics Fibrocell
12:25 pm LUNCH & NETWORKING
1:30 pm PANEL II: THE IMMUNO-ONCOLOGY PIPELINE FOR LIQUID AND SOLID TUMORS
Moderator:
Robert Preti, Ph.D., President and CEO, Hitachi Chemical Advanced Therapeutics Solutions; GM, Hitachi Chemical Regenerative Medicine Business Sector
Speakers:
Samuele Butera, Global Cell and Gene Therapies Business Leader, Novartis Oncology
Jennifer Butler, Chief Commercial Officer and Head of US, Tessa Therapeutics
Derrell Porter, M.D., SVP and Global Commercial Head, Atara Biotherapeutics
Jeffrey Walsh, Chief Financial and Strategy Officer, bluebird bio
2:15 pm COMPANY PRESENTATIONS
West Lounge Room Main Bar Room
2:15 pm MolMed Precision BioSciences
2:30 pm BrainStorm Cell Therapeutics Synpromics
2:45 pm ReNeuron 4D Molecular Therapeutics
3:00 pm AFTERNOON BREAK
3:15 pm PANEL III: GENE THERAPY FOR RARE DISEASES
Moderator:
Reni Benjamin, Ph.D., Managing Director and Senior Biotechnology Analyst, Raymond James
Speakers:
Olivier Danos, Ph.D., Chief Scientific Officer, REGENXBIO
Jeffrey Davis, Chief Operating Officer, Abeona Therapeutics
Matthew Patterson, CEO, Audentes Therapeutics
Arthur Tzianabos, Ph.D., CEO, Homology Medicines
4:00 pm COMPANY PRESENTATIONS
West Lounge Room Main Bar Room
4:00 pm Mesoblast Cellerant Therapeutics
4:15 pm Cynata Therapeutics Regenerex
4:30 pm Capricor Therapeutics inRegen
4:45 pm Sernova Histogen
5:00 pm ViaCyte Thrive Bioscience
5:15 pm NETWORKING RECEPTION
6:30 pm PROGRAM CLOSE